Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

April 10, 2018

Study Completion Date

April 10, 2018

Conditions
Hypertension, Pulmonary
Interventions
OTHER

Telephone concept elicitation interview

All interview questions are designed to be very open-ended in order to ascertain subjects' preferences in an un-biased manner (as possible), with additional probes only being used when necessary to ensure all concepts of interest are covered. Subjects will be asked a series of broad, open-ended questions designed to encourage them to talk openly and as spontaneously as possible about their experience of taking oral treatment(s) for their PAH.

Trial Locations (1)

02210

GSK Investigational Site, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Adelphi Values

UNKNOWN

lead

GlaxoSmithKline

INDUSTRY

NCT03304548 - Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects | Biotech Hunter | Biotech Hunter